Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 132 participants.
Also called NCT02029885
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 132 participants
- Sponsor
- Kona Medical Inc.
- Registry
-
NCT02029885
-
- Other papers using this trial's data
- Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Austria, Colombia, Czechia, Germany, New Zealand, Poland, United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT02029885. Randomized; double masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension
- Acronym
- WAVE_IV
- Condition
- Hypertension
- Intervention (Device)
- Investigational Therapy (Surround Sound)
- Intervention (Device)
- Sham Control
- Lead sponsor
- Kona Medical Inc.
Record details
- Record id
cardio:ct-nct02029885- Content hash
7ddbcdc9ccf8907656b7bb05c9157dd9bc0ad45c6010cf18bcf6c6594e5fa44a